← Back to Search

Behavioural Intervention

Early Exercise for Stroke (BEACH Trial)

N/A
Waitlist Available
Led By Elizabeth K Zink
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up study days 1, 3, 7, on transfer from the icu or discharge from the hospital, whichever comes first, assessed up to 60 days, 30-day follow-up visit
Awards & highlights

BEACH Trial Summary

This trial will compare the inflammatory factors of two groups of brain hemorrhage patients, one of which will receive in-bed cycling in addition to usual care.

Who is the study for?
This trial is for individuals who've had a type of brain hemorrhage and can consent to participate or have someone to consent for them. They should be relatively independent in daily activities before the stroke, not on daily anti-inflammatory meds, without severe injuries that prevent cycling, not excessively overweight, free from inflammatory conditions or infections needing antibiotics, and not pregnant.Check my eligibility
What is being tested?
The study tests if using an in-bed cycle machine early after a brain hemorrhage helps manage inflammation in the brain. Participants are divided into two groups: one does cycling plus standard care starting three days post-hemorrhage; the other receives standard care alone.See study design
What are the potential side effects?
Since this intervention involves physical activity (cycling), potential side effects may include muscle soreness or fatigue. However, as it's gentle exercise designed for hospital settings, serious side effects are unlikely but will be monitored.

BEACH Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~study days 1, 3, 7, on transfer from the icu or discharge from the hospital, whichever comes first, assessed up to 60 days, 30-day follow-up visit
This trial's timeline: 3 weeks for screening, Varies for treatment, and study days 1, 3, 7, on transfer from the icu or discharge from the hospital, whichever comes first, assessed up to 60 days, 30-day follow-up visit for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Absolute Change in Brain Derived Neurotrophic Factor Level in Blood (Picogram/Milliliter)
Absolute Change in Brain Derived Neurotrophic Factor Level in CSF (Picogram/Milliliter)
Absolute Change in Interleukin-6 Level in Blood (Picogram/Milliliter)
+8 more
Secondary outcome measures
Ability to Perform Activities of Daily Living as Assessed by the Barthel Index
Absolute Change in Hand-held Dynamometry Score (Pounds)
Change in Muscle Strength as Assessed by the Medical Research Council Sum (MRCS) Score
+6 more

BEACH Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Supine cycle ergometry of the lower extremitiesExperimental Treatment1 Intervention
Patients will receive two 20 minute cycle ergometry sessions separated by at least 4 hours in addition to usual care. The cycle will be set to a gear of zero and will begin in passive mode, the patient will be able to actively cycle if patients are able.
Group II: ControlActive Control1 Intervention
Patients will receive usual care only.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Supine cycle ergometry of the lower extremities
2019
N/A
~30

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,273 Previous Clinical Trials
14,840,367 Total Patients Enrolled
34 Trials studying Stroke
28,922 Patients Enrolled for Stroke
Elizabeth K ZinkPrincipal InvestigatorJohns Hopkins University

Media Library

Supine cycle ergometry of the lower extremities (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04027049 — N/A
Stroke Research Study Groups: Control, Supine cycle ergometry of the lower extremities
Stroke Clinical Trial 2023: Supine cycle ergometry of the lower extremities Highlights & Side Effects. Trial Name: NCT04027049 — N/A
Supine cycle ergometry of the lower extremities (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04027049 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available slots for participants in this research?

"Per the clinicaltrials.gov website, this experiment is actively seeking participants at present. First posted on March 2nd 2019, it was last modified on January 6th 2022."

Answered by AI

How many individuals have enrolled in this research endeavor?

"Affirmative. The clinical trial is recruiting as indicated on the clinicaltrials.gov website, which was last updated in January 6th 2022 and initially posted on March 2nd 2019. This medical study requires 40 participants at a single site."

Answered by AI

What are the main aims of this research endeavor?

"The primary aim of this experiment, which will be assessed on Day 1, 3 and 7, is to measure the amount of interleukin-1beta in the blood. Secondary endpoints include Functional status as measured by a Modified Rankin Score (MRS) rating from 0-6 (with 6 indicating death), fatigue as evaluated using Promis Scale v1.2 with higher scores illustrating less weariness, and Hand-held dynamometry score (pounds)."

Answered by AI
Recent research and studies
~4 spots leftby May 2025